FPS
REGN icon

Fieldpoint Private Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Fieldpoint Private Securities’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$15K Sell
25
-29
-54% -$18.9K ﹤0.01% 657
2022
Q1 		$38K Buy
54
+5
+10% +$3.16K 0.01% 661
2021
Q4 		$31K Buy
49
+15
+44% +$9.22K 0.01% 741
2021
Q3 		$21K Buy
34
+4
+13% +$2.48K ﹤0.01% 810
2021
Q2 		$18K Sell
30
-70
-70% -$35.5K ﹤0.01% 848
2021
Q1 		$47K Sell
100
-406
-80% -$198K 0.01% 588
2020
Q4 		$244K Buy
506
+25
+5% +$13.5K 0.06% 259
2020
Q3 		$269K Sell
481
-119
-20% -$72.2K 0.08% 241
2020
Q2 		$374K Buy
600
+118
+24% +$67K 0.13% 169
2020
Q1 		$235K Sell
482
-213
-31% -$87.9K 0.09% 212
2019
Q4 		$261K Sell
695
-19
-3% -$6.39K 0.08% 237
2019
Q3 		$198K Sell
714
-51
-7% -$15.1K 0.07% 214
2019
Q2 		$239K Buy
765
+384
+101% +$128K 0.07% 210
2019
Q1 		$156K Buy
381
+28
+8% +$11.5K 0.06% 213
2018
Q4 		$132K Sell
353
-98
-22% -$35.9K 0.06% 220
2018
Q3 		$182K Sell
451
-155
-26% -$59K 0.07% 211
2018
Q2 		$209K Buy
606
+25
+4% +$7.82K 0.08% 203
2018
Q1 		$200K Sell
581
-208
-26% -$72.3K 0.09% 170
2017
Q4 		$297K Sell
789
-232
-23% -$94K 0.16% 131
2017
Q3 		$457K Buy
1,021
+756
+285% +$360K 0.2% 122
2017
Q2 		$130K Buy
+265
New +$116K 0.09% 80

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fieldpoint Private Securities's REGN Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Regeneron Pharmaceuticals (REGN) stake by 54% in Q2 2022, selling an estimated $18.9K and leaving 25 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #657.

Fieldpoint Private Securities first reported a position in REGN in Q2 2017 and has held it in 21 quarters since. The position peaked at $457K in Q3 2017. 1,064 funds tracked by Wall St. Rank hold REGN as of Q2 2022.

  • Fieldpoint Private Securities held 25 shares of Regeneron Pharmaceuticals worth $15K as of Q2 2022.
  • Fieldpoint Private Securities sold 29 Regeneron Pharmaceuticals shares in Q2 2022, an estimated $18.9K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #657 holding.
  • Fieldpoint Private Securities first reported a position in Regeneron Pharmaceuticals in Q2 2017 and has held it in 21 quarters since.
  • Fieldpoint Private Securities's Regeneron Pharmaceuticals position peaked at $457K in Q3 2017.
  • 1,064 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.